Primary Aldosteronism (PA) is defined as non-suppressible hyper secretion of aldosterone by adrenal glands, with consequent suppression of plasma renin activity. It was described by Jerome Conn in 1955. It is said to be an under diagnosed and important secondary endocrine cause of hypertension, and is one of the few potentially curable causes of hypertension using both medical and surgical interventions.
Internal Medicine Open Access accepts all the articles related to primary aldosteronism. Primary aldostronism comes under the field of endocrinology which is a classification of internal medicine. The articles are accepted by Internal Medicine Open Access journal only after a thorough and strict peer review process.
Last date updated on September, 2020